Skip to main content
NVDA+0.10%AAPL-0.38%GOOGL+0.64%MSFT+0.09%AMZN+0.20%TSM+1.02%SPCX-1.36%AVGO+2.97%META+0.35%TSLA-0.11%SKHY+2.46%MU+0.19%BRK-B+0.11%LLY+0.04%JPM+0.10%AMD+2.70%WMT-0.06%V-0.44%XOM+0.17%JNJ-0.09%ASMLa+1.97%INTC-0.18%MA-0.09%0700.HK-1.64%ABBV-0.02%1398.HK-0.27%CSCO-0.66%ORCL-1.98%CVX-0.97%BAC-0.77%COST+0.15%KO+0.22%DELL-3.46%CAT+1.30%LRCX+6.98%0005.HK+1.13%AMAT+6.51%HSBA.L-1.61%PG-0.79%AP2d+5.05%UNH+0.45%3988.HK0.00%GE+0.26%1816.HK-0.24%MS-0.46%HD-0.84%NFLX-4.67%0857.HK-0.73%0939.HK-0.93%ARM+4.04%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDSEK+0.10%EURNZD-0.10%EURZAR-0.09%USDPLN+0.09%NZDCHF+0.07%EURUSD-0.06%EURHKD-0.06%PLNJPY-0.06%AUDCHF+0.06%NZDJPY+0.06%USDDKK+0.06%EURCNH-0.06%GBPZAR-0.05%USDCAD+0.05%EURSGD-0.05%NZDCAD+0.05%USDNOK+0.05%EURCAD-0.05%CHFSEK+0.05%EURSEK+0.05%USDTRY+0.04%AUDDKK+0.04%AUDCAD+0.04%EURAUD-0.04%USDCHF+0.04%USDCOP-0.04%CHFSGD-0.04%AUDNOK+0.04%USDTHB+0.03%USDCNH-0.03%USDJPY+0.03%EURJPY-0.03%EURPLN+0.03%GBPCAD+0.03%GBPCHF+0.03%AUDJPY+0.03%EURGBP-0.03%GBPUSD-0.02%GBPNZD-0.02%CADJPY-0.02%GBPAUD-0.02%USDSGD+0.02%SGDJPY+0.02%GBPJPY+0.02%CHFNOK+0.01%EURNOK-0.01%GBPSGD-0.01%CHFJPY+0.01%NZDMXN-0.01%USDZAR-0.01%NZDSGD+0.01%AUDNZD-0.01%USDHKD-0.01%NZDUSD-0.01%NOKJPY-0.01%USDMXN0.00%EURCZK0.00%EURCHF0.00%AUDSGD0.00%CADCHF0.00%EURDKK0.00%AUDUSD0.00%W1+1.02%C1+0.78%S1+0.72%UKOIL+0.31%USOIL+0.23%XAUUSD-0.21%GAUUSD-0.21%GAGUSD+0.20%XAGUSD+0.20%XPTUSD+0.08%XNGUSD-0.03%HG1+0.03%BTCUSD+0.29%ETHUSD+0.95%USDTUSD0.00%XRPUSD+0.96%SOLUSD+0.63%TRXUSDT+0.96%ZECUSDT+3.50%DOGEUSD+0.30%XMRUSDT+3.42%LINKUSD+1.44%XLMUSD+1.42%UNIUSD+0.66%BCHUSDT-0.44%LTCUSD+1.35%HBARUSDT+7.52%SUIUSD+6.61%TONUSD+24.06%TAOUSDT-0.15%AAVEUSD-2.12%DOTUSDT+1.56%ICPUSDT+1.33%ONDOUSDT+3.79%ARBUSDT+5.96%WLDUSDT+3.23%JUPUSDT+6.61%ATOMUSDT+1.68%INJUSDT-2.69%STXUSDT+7.11%FETUSDT-0.23%TIAUSDT+0.07%PYTHUSDT+1.45%SEIUSDT+10.19%IMXUSDT-0.98%OPUSDT+3.24%GRTUSDT+8.30%POLUSDT+3.78%WIFUSDT-3.69%IOTAUSDT-0.82%AXSUSDT-0.66%FARTCOINUSDT+4.28%EOSUSDT+3.73%DYDXUSDT-1.88%ORDIUSDT+2.31%GALAUSDT+0.77%NOTUSDT+5.67%RONINUSDT-2.70%NVDA+0.10%AAPL-0.38%GOOGL+0.64%MSFT+0.09%AMZN+0.20%TSM+1.02%SPCX-1.36%AVGO+2.97%META+0.35%TSLA-0.11%SKHY+2.46%MU+0.19%BRK-B+0.11%LLY+0.04%JPM+0.10%AMD+2.70%WMT-0.06%V-0.44%XOM+0.17%JNJ-0.09%ASMLa+1.97%INTC-0.18%MA-0.09%0700.HK-1.64%ABBV-0.02%1398.HK-0.27%CSCO-0.66%ORCL-1.98%CVX-0.97%BAC-0.77%COST+0.15%KO+0.22%DELL-3.46%CAT+1.30%LRCX+6.98%0005.HK+1.13%AMAT+6.51%HSBA.L-1.61%PG-0.79%AP2d+5.05%UNH+0.45%3988.HK0.00%GE+0.26%1816.HK-0.24%MS-0.46%HD-0.84%NFLX-4.67%0857.HK-0.73%0939.HK-0.93%ARM+4.04%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDSEK+0.10%EURNZD-0.10%EURZAR-0.09%USDPLN+0.09%NZDCHF+0.07%EURUSD-0.06%EURHKD-0.06%PLNJPY-0.06%AUDCHF+0.06%NZDJPY+0.06%USDDKK+0.06%EURCNH-0.06%GBPZAR-0.05%USDCAD+0.05%EURSGD-0.05%NZDCAD+0.05%USDNOK+0.05%EURCAD-0.05%CHFSEK+0.05%EURSEK+0.05%USDTRY+0.04%AUDDKK+0.04%AUDCAD+0.04%EURAUD-0.04%USDCHF+0.04%USDCOP-0.04%CHFSGD-0.04%AUDNOK+0.04%USDTHB+0.03%USDCNH-0.03%USDJPY+0.03%EURJPY-0.03%EURPLN+0.03%GBPCAD+0.03%GBPCHF+0.03%AUDJPY+0.03%EURGBP-0.03%GBPUSD-0.02%GBPNZD-0.02%CADJPY-0.02%GBPAUD-0.02%USDSGD+0.02%SGDJPY+0.02%GBPJPY+0.02%CHFNOK+0.01%EURNOK-0.01%GBPSGD-0.01%CHFJPY+0.01%NZDMXN-0.01%USDZAR-0.01%NZDSGD+0.01%AUDNZD-0.01%USDHKD-0.01%NZDUSD-0.01%NOKJPY-0.01%USDMXN0.00%EURCZK0.00%EURCHF0.00%AUDSGD0.00%CADCHF0.00%EURDKK0.00%AUDUSD0.00%W1+1.02%C1+0.78%S1+0.72%UKOIL+0.31%USOIL+0.23%XAUUSD-0.21%GAUUSD-0.21%GAGUSD+0.20%XAGUSD+0.20%XPTUSD+0.08%XNGUSD-0.03%HG1+0.03%BTCUSD+0.29%ETHUSD+0.95%USDTUSD0.00%XRPUSD+0.96%SOLUSD+0.63%TRXUSDT+0.96%ZECUSDT+3.50%DOGEUSD+0.30%XMRUSDT+3.42%LINKUSD+1.44%XLMUSD+1.42%UNIUSD+0.66%BCHUSDT-0.44%LTCUSD+1.35%HBARUSDT+7.52%SUIUSD+6.61%TONUSD+24.06%TAOUSDT-0.15%AAVEUSD-2.12%DOTUSDT+1.56%ICPUSDT+1.33%ONDOUSDT+3.79%ARBUSDT+5.96%WLDUSDT+3.23%JUPUSDT+6.61%ATOMUSDT+1.68%INJUSDT-2.69%STXUSDT+7.11%FETUSDT-0.23%TIAUSDT+0.07%PYTHUSDT+1.45%SEIUSDT+10.19%IMXUSDT-0.98%OPUSDT+3.24%GRTUSDT+8.30%POLUSDT+3.78%WIFUSDT-3.69%IOTAUSDT-0.82%AXSUSDT-0.66%FARTCOINUSDT+4.28%EOSUSDT+3.73%DYDXUSDT-1.88%ORDIUSDT+2.31%GALAUSDT+0.77%NOTUSDT+5.67%RONINUSDT-2.70%
CH

Chemed Corporation (CHE)

NYSE • Healthcare

$504.06
-$1.91 (-0.4%)
Market closed

Last close at September 18, 2026 at 20:00 UTC

Open$504.5
Day Range$498.23 - $512.25
Avg. Volume (3M)154.3K
Market Cap$6.5B
P/E Ratio25.3
52 Week Range
$365.21$557
Next EarningsIn 36 daysOct 27, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$673.2M100%
Gross Profitminus cost of goods$204.4M30%
Operating Incomeminus R&D and overhead$89.2M13%
Net Incomeminus taxes and the rest$67.7M10%

In plain terms: out of every $100 in revenue, Chemed Corporation keeps $10 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.5B
Net Income (TTM)
$274.9M
EPS (TTM)
$19.92
ROA (TTM)
17.41%
Current Ratio
0.91
Dividend Yield
0.13%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-8.5%Q1 2026$6.42
+6.6%Q2 2026$5.65
+8.2%Q3 2026$6.06
Next

Oct 27

in 36 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +8.2%

Chemed beat expectations on both the top and bottom line in the second fiscal quarter of 2026, based on preliminary results reported July 28, as revenue rose ~9% to about $673.3 million, edging the $665.0 million estimate by +1.2%, and adjusted EPS of $6.06 topped the $5.60 estimate by +8.2% and rose ~42% from $4.27 a year ago. Net income increased 29% to roughly $67.7 million from $52.5 million a year ago, while operating income came in at about $89.2 million. Operating cash flow was about $84.8 million, and Chemed repurchased about $97.5 million of stock and paid about $7.9 million in dividends. Consensus for the next period calls for EPS of $6.01 on revenue of $674.1 million.

View full earnings history

About Chemed Corporation

Chemed Corporation operates in healthcare services on the New York Stock Exchange as CHE, centered on hospice and palliative care services and home-based patient support through VITAS while also owning the service business Roto-Rooter. In FY2025, Chemed generated $2.5 billion in revenue.

Name
Chemed Corporation
CEO
Kevin J. McNamara
Website
www.chemed.com
Industry
Healthcare
Year Founded
1970
Employees
15,811

Today's Snapshot

AI-generated

CHE closed slightly lower at 504.06, in line with a flat sector. Shares changed hands at roughly three times its usual level. Brokerages gave Chemed a neutral rating.

Trading Volume

Above 10d avg 150.2K

414.2K

vs S&P 500 Today

Moderate Underperformance

-0.46%

Updated: September 18, 2026 at 20:24 UTC

Technical Indicators

3 Buy1 Neutral4 Sell
CHE displays a mixed technical profile with short- and medium-term averages above the price while the 100- and 200-day averages remain below, producing a sideways-to-slightly-biased environment. Momentum measures are negative—MACD and recent price momentum lean down—while RSI and MFI are subdued rather than extreme. ADX is low, indicating limited trend strength, ATR shows moderate volatility, and OBV points to slight distribution; the pivot is marginally higher than the market. Technical takeaway: conflicting short-term weakness versus longer-term support yields a neutral technical stance.
All signals
  • EMA (5 indicators)$467.68 - $517.56
    Sell
  • RSI (14)37.38
    Neutral
  • Stochastic %K (14, 3, 3)19.55
    Buy
  • MACD Level (12, 26)-4.75
    Sell

Peers & Related Assets

DVADaVita Inc.
$183.86+0.4%
BTSGBrightSpring Health Services, Inc. Common Stock
$56.78+0.3%
HSICHenry Schein, Inc.
$84.84-0.2%
BRKRBruker Corporation
$61.39-2.6%
NUVLNuvalent, Inc.
$123.960.0%
ATRAptarGroup, Inc.
$124.44-0.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.